Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-09
2010-02-16
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S417000
Reexamination Certificate
active
07662847
ABSTRACT:
The invention encompasses novel N-alkyl-hydroxamic acid-isoindolyl compounds, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions for treatment or prevention of various diseases and disorders, for example, diseases associated with PDE4.
REFERENCES:
patent: 5605914 (1997-02-01), Muller et al.
patent: 6214857 (2001-04-01), Muller et al.
patent: 6667316 (2003-12-01), Man et al.
patent: 6699899 (2004-03-01), Man et al.
patent: WO 02/081447 (2002-10-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227.
Vippagunta et al., Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
Man Hon-Wah
Muller George W.
Celgene Corporation
Jones Day
Stockton Laura L.
LandOfFree
Methods of using N-alkyl-hydroxamic acid-isoindolyl compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using N-alkyl-hydroxamic acid-isoindolyl compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using N-alkyl-hydroxamic acid-isoindolyl compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4162080